Rolling record / ARQ 63 Concerning · ▲ +2 7-day 3595 events in window / as of 02 Oct 2026
ARQAI Risk Quotient
medicine 32.8 Low risk

CellCarta and Imagene AI Expand Collaboration for AI-Powered Biomarker Programs

This collaboration advances AI integration in drug development, potentially improving diagnostics and patient outcomes.

This collaboration advances AI integration in drug development, potentially improving diagnostics and patient outcomes.

Auto-scored: Low-risk positive development in AI for healthcare.